JAC Advance Access originally published online on October 16, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 52, 764-771
© 2003 The British Society for Antimicrobial Chemotherapy
Review |
Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing
1 Health Services Research Unit, University of Aberdeen, Aberdeen; 2 Department of Microbiology, Frenchay Hospital, Bristol; 3 Department of Pathology and Microbiology, University of Bristol, Bristol; 4 MEMO, Department of Clinical Pharmacology, University of Dundee, Dundee DD1 9SY, UK
Received 18 June 2003; returned 17 August 2003; revised 28 August 2003; accepted 28 August 2003
Introduction: In 1999, the British Society for Antimicrobial Chemotherapy (BSAC) and Hospital Infection Society (HIS) convened a working party on optimization of antibiotic prescribing in hospitals. This study was undertaken in order to evaluate the current evidence base on the effectiveness of interventions to change antibiotic prescribing to hospital inpatients.
Methods: We have systematically reviewed the literature from 1980 to identify interventions that alone, or in combination, are effective in improving antibiotic prescribing to hospital inpatients. The protocol was peer reviewed and has been published by the Effective Practice and Organization of Care (EPOC) Group of the Cochrane Collaboration (www.update-software.com/cochrane/).
Results: We identified 306 papers, of which 91 (30%) met the minimum inclusion criteria for a Cochrane EPOC review. The reasons for exclusion were uncontrolled before and after design (141/306; 46%) and inadequate interrupted time series (74/306; 24%) with fewer than three observations before and after the intervention. Most of the rejected interrupted time series (ITS) studies had only one or two data points before the intervention with many (up to 15) after it. Only 15 (40%) of the 38 included ITS studies had a statistical analysis and 11 of these used inappropriate statistical tests (e.g. t-test of pre- and post-intervention mean data) rather than analysis of time trends. Regression analysis of the proportion of included studies by year of publication did show a significant positive correlation (R2 = 0.7886). Nonetheless, of 47 papers published since 2000, only 19 (40%) met the minimum eligibility criteria.
Conclusions: The majority of evaluations used fundamentally flawed methodology. There is limited evidence of improvement over time. These problems could be resolved if researchers and referees of protocols or manuscripts implemented the EPOC methodology.
Keywords: prescribing interventions, controlled before and after studies, interrupted time series, segmented regression analysis, hospital antibiotic prescribing
* Corresponding author. Tel: +44-1382-632575; Fax: +44-1382-642637; E-mail: peter{at}memo.dundee.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Mertz, M. Koller, P. Haller, M. L. Lampert, H. Plagge, B. Hug, G. Koch, M. Battegay, U. Fluckiger, and S. Bassetti Outcomes of early switching from intravenous to oral antibiotics on medical wards J. Antimicrob. Chemother., July 1, 2009; 64(1): 188 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. F. Chaberny, F. Schwab, S. Ziesing, S. Suerbaum, and P. Gastmeier Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis J. Antimicrob. Chemother., December 1, 2008; 62(6): 1422 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Kim and M. J. Kim Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae by utilizing a computer-assisted management program to restrict third-generation cephalosporin use--authors' response J. Antimicrob. Chemother., November 1, 2008; 62(5): 1165 - 1166. [Full Text] [PDF]
|
|
|
|
|
|
K. L. Buising, K. A. Thursky, M. B. Robertson, J. F. Black, A. C. Street, M. J. Richards, and G. V. Brown Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting J. Antimicrob. Chemother., September 1, 2008; 62(3): 608 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cooke and on behalf of the Prescribing Subgroup of SACAR Report of the Prescribing Subgroup of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) J. Antimicrob. Chemother., August 1, 2007; 60(suppl_1): i9 - i13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hand Antibiotic pharmacists in the ascendancy J. Antimicrob. Chemother., August 1, 2007; 60(suppl_1): i73 - i76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Meyer, J. Buttler, C. Schneider, E. Strehl, B. Schroeren-Boersch, P. Gastmeier, H. Ruden, J. Zentner, F. D. Daschner, and F. Schwab Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced J. Antimicrob. Chemother., June 1, 2007; 59(6): 1148 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fowler, A. Webber, B. S. Cooper, A. Phimister, K. Price, Y. Carter, C. C. Kibbler, A. J. H. Simpson, and S. P. Stone Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series J. Antimicrob. Chemother., May 1, 2007; 59(5): 990 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Stone, B. S. Cooper, C. C. Kibbler, B. D. Cookson, J. A. Roberts, G. F. Medley, G. Duckworth, R. Lai, S. Ebrahim, E. M. Brown, et al. The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection J. Antimicrob. Chemother., May 1, 2007; 59(5): 833 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Itokazu, D. N. Schwartz, K. W. Garey, K. A. Rodvold, L. H. Danziger, and R. A. Weinstein Pharmacists' perceptions of the effectiveness of antimicrobial control programs Am. J. Health Syst. Pharm., December 15, 2006; 63(24): 2504 - 2508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Wickens and A. Jacklin Impact of the Hospital Pharmacy Initiative for promoting prudent use of antibiotics in hospitals in England J. Antimicrob. Chemother., December 1, 2006; 58(6): 1230 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Thursky, K. L. Buising, N. Bak, L. Macgregor, A. C. Street, C. R. Macintyre, J. J. Presneill, J. F. Cade, and G. V. Brown Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit Int. J. Qual. Health Care, June 1, 2006; 18(3): 224 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. E. van Kasteren, J. Mannien, B.-J. Kullberg, A. S. de Boer, N. J. Nagelkerke, M. Ridderhof, J. C. Wille, and I. C. Gyssens Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis J. Antimicrob. Chemother., December 1, 2005; 56(6): 1094 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. MacDougall and R. E. Polk Antimicrobial Stewardship Programs in Health Care Systems Clin. Microbiol. Rev., October 1, 2005; 18(4): 638 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Huang, L. Morlock, C.-H. Lee, L.-S. Chen, and Y.-J. Chou Antibiotic Prescribing for Children With Nasopharyngitis (Common Colds), Upper Respiratory Infections, and Bronchitis Who Have Health-Professional Parents Pediatrics, October 1, 2005; 116(4): 826 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. M. Mol, J. E. Wieringa, P. V. NannanPanday, R. O. B. Gans, J. E. Degener, M. Laseur, and F. M. Haaijer-Ruskamp Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis J. Antimicrob. Chemother., April 1, 2005; 55(4): 550 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Peterson and A. Dalhoff Towards targeted prescribing: will the cure for antimicrobial resistance be specific, directed therapy through improved diagnostic testing? J. Antimicrob. Chemother., June 1, 2004; 53(6): 902 - 905. [Abstract] [Full Text] [PDF]
|
|